SIREN : 514163757
FLYHEALTH is a French company founded 16 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in MANDELIEU-LA-NAPOULE (06210), this company of category PME shows in 2024 a revenue of 420 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 420 495 € | 342 553 € | 301 515 € | 281 057 € | 231 000 € | 256 667 € | 256 667 € | 256 667 € | 258 454 € |
| Net income | 98 939 € | 7 442 € | 335 € | 42 993 € | 45 327 € | 35 359 € | 26 099 € | 31 452 € | 5 890 € |
| EBITDA | 126 618 € | 15 357 € | 8 771 € | 29 061 € | 33 454 € | 19 490 € | 10 794 € | 16 255 € | 11 235 € |
| Net margin | 23.5% | 2.2% | 0.1% | 15.3% | 19.6% | 13.8% | 10.2% | 12.3% | 2.3% |
In 2024, FLYHEALTH achieves revenue of 420 k€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +6.3%. Vs 2023, growth of +23% (343 k€ -> 420 k€). After deducting consumption (0 €), gross margin stands at 420 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 127 k€, representing 30.1% of revenue. Positive scissor effect: EBITDA margin improves by +25.6 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 99 k€, i.e. 23.5% of revenue. This profit can be retained or distributed to shareholders.
420 495 €
420 495 €
126 618 €
122 625 €
98 939 €
30.1%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 24.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.885%
87.701%
24.401%
0.032
42.4%
In 2024, the debt ratio of FLYHEALTH (0.89) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of FLYHEALTH (87.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of FLYHEALTH (0.03) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 849.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.
849.289
0.22
In 2024, the liquidity ratio of FLYHEALTH (849.29) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of FLYHEALTH (0.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 31 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 11 days. The company must finance 20 days of gap between collections and payments. Overall, WCR represents 85 days of revenue, i.e. 99 k€ to permanently finance. Over 2016-2024, WCR increased by +237%, requiring additional financing.
98 791 €
31 j
11 j
0 j
85 j
Based on 131 transactions of similar company sales (all years), the value of FLYHEALTH is estimated at 417 623 € (range 134 288€ - 806 374€). With an EBITDA of 126 618€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare FLYHEALTH with other companies in the same sector:
Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.
The revenue of FLYHEALTH in 2024 is 420 k€.
Yes, FLYHEALTH generated a net profit of 99 k€ in 2024.
The headquarters of FLYHEALTH is located in MANDELIEU-LA-NAPOULE (06210), in the department Alpes-Maritimes.
The tax return of FLYHEALTH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
FLYHEALTH operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.